IFNAR1 and Zika virus infectious disease: In order to test this hypothesis, PCNs from B6 embryos were treated before and throughout ZIKV infection with either the MAR1-5A3 anti-IFNAR antibody or recombinant IFNB (recIFNB) (Fig. 2).